ライフサイエンスコーパス: radiochemical

1 ained previously for 32P-orthophosphate, the radiochemical 117mSn(4+)DTPA yields up to an 8-fold ther

2 incorporation of the alpha-particle-emitting radiochemical ((210)Po-citrate) and 2 anticancer drugs (

3 Radiochemical analysis demonstrated that the postpurific

4 assisted laser-desorption/time of flight and radiochemical analysis of the product generated in vitro

5 eatment procedures has been validated in the radiochemical analysis of total (99)Tc in caustic aged n

6 TPMT activity was measured by radiochemical analysis, TPMT genotype was determined by

7 F-GLN and (18)F-(2S,4R)4F-GLU with confirmed radiochemical and enantiomeric purity.

8 (13)C]-3, and [2',3'-(13)C]-3 as substrates, radiochemical and NMR analyses of incubation mixtures re

9 Mean radiochemical and product yields and purities were 90%,

10 ertechnetate 99mTc was assayed for chemical, radiochemical, and radionuclidic purity.

11 es such compounds interesting candidates for radiochemical applications.

12 thelial cells, studies of drug release using radiochemical approaches showed that the presence of 10v

13 inefficient and/or poorly defined multistep radiochemical approaches.

14 We have developed a simple and sensitive radiochemical assay to determine malonyl-CoA decarboxyla

15 A simple quantitative radiochemical assay was developed for ArnB, which can be

16 An in vitro radiochemical assay was used to study the inhibitory eff

17 This assay has an advantage over traditional radiochemical assays in that many substrates, the substr

18 luorescent assay combines the sensitivity of radiochemical assays with the simplicity of nonradiochem

19 In characterizing AdPLA, we employed radiochemical assays with TLC analysis of the enzyme act

20 ntages over the more traditional assay using radiochemical ATP and column chromatography.

21 diosynthesis of 5'-[(18) F]FDA, with overall radiochemical conversion (RCC) more than 3-fold higher t

22 abeled isoquinolines resulting in up to 92 % radiochemical conversion.

23 beling of a variety of carboxylic acids with radiochemical conversions up to 50 %, representing a tar

24 erformance liquid chromatography (HPLC) with radiochemical detection to determine relative levels of

25 e was measured by immunohistochemistry, with radiochemical detection.

26 ontrol chemistries that are required for the radiochemical determination of total (99)Tc in caustic a

27 ning pharmaceuticals were prepared with high radiochemical efficiency.

28 We also found immunological and radiochemical evidence that LANA is subject to lysine ac

29 However, this radiochemical has also been reported to induce cell-cycl

30 ypoxia could be useful tools that complement radiochemical imaging and immunohistochemical staining m

31 se findings were supported by the results of radiochemical in situ hybridization histology and quanti

32 Previous radiochemical incorporation experiments and bioinformati

33 results supersede proposals based on earlier radiochemical incorporation experiments.

34 ack of chemically diverse precursors, and of radiochemical methods allowing (18)F-incorporation in hi

35 This method could replace radiochemical methods and could trace the incorporation

36 ably, unlike prior studies using established radiochemical methods in synaptosomes, we determined 60%

37 h ruggedness tests, the application field of radiochemical methods used was extended successfully to

38 A radiochemical neutron activation analysis procedure has

39 orobenzaldehyde using an aniline-accelerated radiochemical oximation reaction.

40 -SFB was efficiently prepared using a 3-step radiochemical pathway.

41 The radiochemical procedure was validated by its application

42 rably with those obtained by a commonly used radiochemical procedure, which measures transamination b

43 mparable to those obtained previously by the radiochemical procedure.

44 low normal organ uptake, as well as superior radiochemical properties.

45 elds of 61% (decay-corrected) or greater and radiochemical purities greater than 99%.

46 The chemical and radiochemical purities of (18)F-F13714 were greater than

47 The chemical and radiochemical purities of [(11)C]10 were >99% with a spe

48 orT in radiochemical yields of about 30% and radiochemical purities of greater than 99%.

49 corrected yields ranging from 60% to 70% and radiochemical purities of more than 99%.

50 Chemical and radiochemical purities of TP3939 were 96.8% and 98% +/-

51 of the tributyltin analogues in high yields, radiochemical purities, and specific radioactivities.

52 yl]temozolomide (11), with good chemical and radiochemical purities, have been prepared and used in h

53 activities (45-95 GBq/mumol), and excellent radiochemical purities.

54 cal purity suitable for biologic evaluation (radiochemical purity > 95%, decay-corrected radiochemica

55 c activity of 37,000--444,000 GBq/mmol and a radiochemical purity > 99%.

56 We synthesized [(14)C]TETS (14 mCi/mmol, radiochemical purity >99%) by reacting sulfamide with H(

57 a 51% +/- 19% radiochemical yield with high radiochemical purity (>/=98%).

58 ribed in this study could be labeled to high radiochemical purity (>95%, 2.2-4.5 MBq/nmol).

59 des, can be synthesized in good chemical and radiochemical purity (>98%), satisfactory radiochemical

60 ochemical yield of 2 +/- 0.6% with excellent radiochemical purity (>99%) and showed complete stabilit

61 iochemical yield (36% +/- 7% [mean +/- SD]), radiochemical purity (>99%), and mean molar activity (1,

62 u]-NPs of uniform shape and size with a high radiochemical purity (>99%), specific activity of 2.2 mC

63 s developed, providing a radiotracer of high radiochemical purity (>99%).

64 d high yields (>78% decay-corrected) in high radiochemical purity (>99%).

65 radiochemical yield (24-52% n = 8) and high radiochemical purity (>99%).

66 chemical yield, respectively, with excellent radiochemical purity (>99%).

67 fluorination, affording a product with >99% radiochemical purity (RCP) and specific activity (SA) of

68 efficient, resulting in ADCs with 96% to 98% radiochemical purity after size-exclusion chromatography

69 The radiochemical purity after solid-phase extraction purifi

70 A-hu14.18K322A was achieved at more than 95% radiochemical purity and a specific activity of 127-370

71 -fluoromaltotriose was synthesized with high radiochemical purity and evaluated in several clinically

72 ng procedure yielded a compound with 95%-99% radiochemical purity and good in vitro stability.

73 (11)C-LY2459989 was synthesized in high radiochemical purity and good specific activity.

74 vides radiolabeled peptides with high (>98%) radiochemical purity and greater than 80% radiochemical

75 05270430 was synthesized in greater than 98% radiochemical purity and high specific activity.

76 g with 99mTc via 2-iminothiolane thiolation, radiochemical purity and radiostability were tested.

77 Chemical and radiochemical purity and serum stability were determined

78 efficiently with 111In or (99m)Tc with high radiochemical purity and specific activities.

79 ing antibody trastuzumab and labeled in high radiochemical purity and specific activity with the radi

80 The radiochemical purity and stability of the compound was a

81 Radiochemical purity and sterility were examined.

82 )(3)(ASMA) preparations had greater than 99% radiochemical purity and were stable in phosphate-buffer

83 ine) could be completed in 25 min, with >99% radiochemical purity and with no coligands present.

84 btained in the (18)F-radiolabeled form, with radiochemical purity and yield suitable for preliminary

85 /D3 receptor by carbonylation with excellent radiochemical purity and yield.

86 ]Cu-NOTA-HsTX1[R14A] was synthesised in high radiochemical purity and yield.

87 ined in 25 min (n = 5) with greater than 99% radiochemical purity at high specific activity (>111 GBq

88 The radiochemical purity exceeded 99% in all syntheses.

89 up to 1.5 GBq of tracer were produced with a radiochemical purity greater than 95% in less than 30 mi

90 cluding work-up took about 20-30 min, with a radiochemical purity greater than 95% without the need f

91 ne, patient batches (>200 applications) with radiochemical purity greater than 98% and specific activ

92 f 8.0 x 10(7) MBq/mmol (2,166 Ci/mmol) and a radiochemical purity greater than 98%.

93 y in the range of 888-3,774 GBq/mumol, and a radiochemical purity greater than 99% using an automatic

94 DFO-AC-10 with a radiochemical yield of 80%, radiochemical purity greater than 99%, and specific acti

95 of (11)C-cholylsarcosine was produced with a radiochemical purity greater than 99%.

96 uncorrected for decay) and greater than 98% radiochemical purity in a synthesis time of 10 min.

97 99mTc-C2A-GST had a radiochemical purity of >98% and remained stable.

98 DOTA-VEGF(121) was 3.2 +/- 0.1 GBq/mg with a radiochemical purity of >98%.

99 n +/- SD) in approximately 35 min and with a radiochemical purity of >99%.

100 a radiochemical yield of 10-15% (EOB) and a radiochemical purity of >99%.

101 The radiochemical purity of (64)Cu-TP3805 was 97% +/- 2%, an

102 The radiochemical purity of (99m)Tc-annexin V was >95%.

103 ith a radiochemical yield of 15.1% +/- 5.6%, radiochemical purity of 96.7% +/- 2.0%, and specific act

104 overall recovery yield of 91 +/- 3%, average radiochemical purity of 99.9%, and production yields tha

105 The radiochemical purity of both (68)Ga-DOTATOC and (68)Ga-P

106 MSB0010853 with (89)Zr was performed with a radiochemical purity of greater than 95%.

107 specific activity of 52-224 MBq/nmol, and a radiochemical purity of more than 97% (90 min from end o

108 Anti-CD56 mAb was radiolabeled, achieving a radiochemical purity of more than 97% and a specific act

109 activity of approximately 20 GBq/mumol and a radiochemical purity of more than 98% for (64)Cu-NOTA-AE

110 lated in an overall yield of 68% +/- 5% with radiochemical purity of more than 99.5%.

111 The radiochemical purity of Na(2)[(99m)Tc(CO)(3)(NTA)] was g

112 The radiochemical purity of the (18)F-DEG-VS-NT was greater

113 The radiochemical purity of the 18F-labeled peptides was >98

114 The radiochemical purity of the labeled phage exceeded 95% b

115 ed with a (99m)Tc-tricarbonyl precursor, and radiochemical purity of the labeled products was determi

116 High radiochemical purity of the target compound is also achi

117 nation in 52-66% decay-corrected yields with radiochemical purity over 99%.

118 e (18)F-SO3F(-) was simple and afforded high radiochemical purity suitable for biologic evaluation (r

119 Radiochemical purity was >99% and average specific activ

120 The radiolabeling efficiency was 80%-85%, radiochemical purity was 78%-89%, and specific activity

121 A high radiochemical purity was achieved without an incubation

122 Radiochemical purity was assessed by high-performance li

123 of 56% +/- 8% (non-decay-corrected), and the radiochemical purity was greater than 95%.

124 specific activity was 15-170 GBq/mumol, and radiochemical purity was greater than 97% (end of synthe

125 l yield was 1.40% +/- 0.16% (n = 4), and the radiochemical purity was greater than 98%.

126 /- 2 GBq/mumol (0.19 +/- 0.05 Ci/mumol), and radiochemical purity was greater than 99%.

127 (18)F-l-FEHTP specific activity and radiochemical purity were 50-150 GBq/mumol and greater t

128 ochemical yield, 5% at the end of synthesis; radiochemical purity, >95%).

129 %-45%; specific activity, 650-870 GBq/mumol; radiochemical purity, >99%).

130 radiochemical yield (decay corrected), high radiochemical purity, and >90 GBq/mumol specific radioac

131 ith a PET nuclide at high specific activity, radiochemical purity, and yield.

132 The complexes were isolated in high radiochemical purity, as determined by radio-thin-layer

133 ontrol requirements for human use (including radiochemical purity, residual solvents, Kryptofix, chem

134 Radiochemical purity, stability up to 260 min, and bindi

135 After testing for radiochemical purity, three anesthetized Dutch-belted ra

136 cted radiochemical yields with more than 99% radiochemical purity.

137 an average yield of 12% and greater than 99% radiochemical purity.

138 probe was synthesized with greater than 98% radiochemical purity.

139 ge of 5-10% radiochemical yield and over 95% radiochemical purity.

140 end of synthesis (n = 17), and more than 99% radiochemical purity.

141 s only 25 min to prepare and results in >99% radiochemical purity.

142 abeled compounds with 15%-20% yield and >95% radiochemical purity.

143 ine compounds were labeled with 64Cu in high radiochemical purity.

144 sized in 20-40% radiochemical yield and >98% radiochemical purity.

145 % radiochemical yields with greater than 98% radiochemical purity.

146 he aqueous beam stop was recovered with >99% radiochemical purity.

147 mumol specific activity and greater than 95% radiochemical purity.

148 The rapid radiochemical reaction time (</=1 min) and high function

149 Additionally, the method results in high radiochemical recoveries and when compared to other dige

150 provides a self-diagnostic parameter for the radiochemical separation and overall instrument function

151 The proposed radiochemical separation can be completed within 2days f

152 A radiochemical separation procedure was developed to isol

153 e complete process of the sample collection, radiochemical separation, and measurement procedure spec

154 Based upon this radiochemical sequence analysis, [(3)H]Ro15-4513 was fou

155 Protease cleavage and radiochemical sequencing identified receptor residue Leu

156 Radiochemical sequencing identified receptor residue Tyr

157 rification, proteolytic peptide mapping, and radiochemical sequencing of labeled wild-type and mutant

158 by this probe was identified as Glu(133) by radiochemical sequencing.

159 ars, and the current trend suggests that the radiochemical space available for PET applications will

160 ese medicinally important motifs expands the radiochemical space available for PET applications.

161 Radiochemical stability of (99m)Tc-RYM1 was evaluated by

162 In vitro radiochemical sugar incorporation assays using these pur

163 We developed an efficient radiochemical synthesis for both 7alpha-18F-FM-DHT and 7

164 p decay and its ramifications (including the radiochemical synthesis of one organometallic compound),

165 cific activity, higher affinity, and simpler radiochemical synthesis than (18)F-BF4(-) METHODS: The a

166 cific activity, higher affinity, and simpler radiochemical synthesis than (18)F-BF4(-) The ability of

167 PTK7, was labeled with (18)F using a 2-step radiochemical synthesis, which featured a direct 1-step

168 nd 14 control eyes; age range, 62-93 years), radiochemical techniques were used to determine the RPE

169 It is therefore desirable to identify radiochemicals that minimize the dose to the bone marrow

170 adiopharmaceutical compared with a reference radiochemical was quantitated as a dosimetric relative a

171 (89)Zr-DFO-J591 was produced in high radiochemical yield (>77%) and purity (>99%), with a spe

172 Zr, scVR1/Zr, and scVR2/Zr tracers with high radiochemical yield (>87%), high specific activity (>/=9

173 ively] were radiofluorinated at a reasonable radiochemical yield (13%-18%) by use of site-specific ox

174 iomers of [(18)F]FAMPe were obtained in good radiochemical yield (24-52% n = 8) and high radiochemica

175 cursor, (18)F-LY2459989 was prepared at high radiochemical yield (36% +/- 7% [mean +/- SD]), radioche

176 [(64)Cu]3-7 were prepared in high radiochemical yield (60-90%) and purity (>95%).

177 -99m complexes [TcO(SN(R)S)(SNX(2))] in high radiochemical yield (60-98%).

178 with fluorine-18 (t1/2 = 109.7 min) in high radiochemical yield (87%) by treatment of its synthesize

179 (18)F-7 was obtained in up to 20% radiochemical yield (decay corrected), high radiochemica

180 with [11C]methyl iodide in approximately 30% radiochemical yield (decay-corrected to end of bombardme

181 e synthesized in 45% (n = 5) and 42% (n = 4) radiochemical yield (decay-corrected to end of bombardme

182 and [(18)F](S)-FIPCT were synthesized in 5% radiochemical yield (decay-corrected to end of bombardme

183 c activity [123I]ZIET was synthesized in 33% radiochemical yield (decay-corrected) by treating the 2b

184 (18)F-FHNP was obtained in 15%-40% radiochemical yield (decay-corrected), with a specific a

185 (18)F-FPA was synthesized in 44% overall radiochemical yield (decay-corrected).

186 -protected 5-O-mesylate precursors in 17-35% radiochemical yield (decay-corrected).

187 led peptide can be obtained with a 31 +/- 6% radiochemical yield (n = 4, decay-corrected from (18)F-f

188 ried (18)F and purified via a C18 cartridge (radiochemical yield 49.8% +/- 5.9% within 20-25 min) wit

189 (radiochemical purity > 95%, decay-corrected radiochemical yield = 31.6%, specific activity >/= 48.5

190 FCH was synthesized in 20-40% radiochemical yield and >98% radiochemical purity.

191 GMIB-Nanobody was produced in 50.4% +/- 3.6% radiochemical yield and exhibited a dissociation constan

192 d 7alpha-18F-FM-norT, producing them in good radiochemical yield and high specific activity.

193 (18)F-FNDP can be synthesized in suitable radiochemical yield and high specific radioactivity and

194 iolabeling method capable of generating high radiochemical yield and high specific radioactivity.

195 d a method for preparing [(18)F]11 in useful radiochemical yield and in high specific activity from [

196 through radiomethylation in a range of 5-10% radiochemical yield and over 95% radiochemical purity.

197 E) and (99m)Tc-PSMA-I&S in consistently high radiochemical yield and purity (>/=98%, n > 50 preparati

198 poration in high selectivity and efficiency (radiochemical yield and purity, specific activity, and r

199 mpounds (86)Y- 4: - 6: were obtained in high radiochemical yield and purity, with specific radioactiv

200 produce no-carrier-added products with high radiochemical yield and purity.

201 din-4 was labeled with 89Zr and 68Ga in high radiochemical yield and purity.

202 All 5 tracers were produced with good radiochemical yield and specific activity.

203 yl)- N,N-diethylacetamide ((18)F-6b) in high radiochemical yield and specific activity.

204 hod using isotopic exchange gives suboptimal radiochemical yield and specific activity.

205 l of the compounds were produced in adequate radiochemical yield and specific radioactivity (>74 GBq/

206 n approach proved to be superior in terms of radiochemical yield and stability, as well as in vivo pe

207 The decay-corrected radiochemical yield for (18)F-FPRGD4 was about 15%, with

208 g of cm09 was achieved in a greater than 96% radiochemical yield for all terbium radioisotopes.

209 4-(11)C-carbonyl]temozolomide (11) in 10-15% radiochemical yield from [(11)C-carbonyl]methyl isocyana

210 [3-N-(11)C-methyl]temozolomide (9) in 14-20% radiochemical yield from [(11)C-methyl]methyl isocyanate

211 -aspergillitine is prepared in 10 % isolated radiochemical yield from the corresponding phenyl(asperg

212 (18)F-FBzBMS 5 was synthesized with 0.54% radiochemical yield in 130 min, with an average specific

213 uorobenzoyl)insulin ((18)F-4b) in 6% overall radiochemical yield in 240 min.

214 (11)C-Compound 1 was synthesized at an 8% radiochemical yield in 29 min with an average specific r

215 (11)C-BMS-5p 3 was synthesized with 1.5% radiochemical yield in 36 min, with an average specific

216 The overall radiochemical yield in hu3S193 labeling and purification

217 Typical decay-corrected radiochemical yield is 23% +/- 2% (n = 20).

218 The radiochemical yield of (11)C-metformin was 15% +/- 3% (n

219 The radiochemical yield of (18)F-FB-IL2 after high-performan

220 The combined two step reaction gave a radiochemical yield of 10-15% (EOB) and a radiochemical

221 -trastuzumab-ThioFab) in 82 min with a total radiochemical yield of 13 +/- 3% and a specific activity

222 nstant, 1.73 nM) was prepared in 1 step in a radiochemical yield of 14% +/- 7%, specific radioactivit

223 orobenzoate, with an overall decay-corrected radiochemical yield of 15% +/- 5% calculated from the st

224 NOTA-ZPD-L1_1 was labeled, with a radiochemical yield of 15.1% +/- 5.6%, radiochemical pur

225 (18)F-PC-10 was synthesized with a radiochemical yield of 16% +/- 3% (decay-corrected).

226 corresponding tosylate precursor in a modest radiochemical yield of 2 +/- 0.6% with excellent radioch

227 nd radiochemical purity (>98%), satisfactory radiochemical yield of 20-35% (n > 20, non-decay correct

228 d conditions, (18)F-TFB was synthesized in a radiochemical yield of 20.0% +/- 0.7% (n = 3, uncorrecte

229 thesis process within 57 min with an overall radiochemical yield of 21%, decay-corrected.

230 We obtained (18)F-FAC in a radiochemical yield of 55% +/- 5% (mean +/- SD) in appro

231 rification, (68)Ga-HZ220 was obtained with a radiochemical yield of 56% +/- 8% (non-decay-corrected),

232 abeled efficiently with (18)F in an isolated radiochemical yield of 62% +/- 2%, non-decay-corrected b

233 action purification with a decayed-corrected radiochemical yield of 63% +/- 5% (n = 5) and passed all

234 r to give formulated (89)Zr-DFO-AC-10 with a radiochemical yield of 80%, radiochemical purity greater

235 is time was 120 min, and the decay-corrected radiochemical yield of [(18)F]- 1 was about 25-30% ( n =

236 The radiochemical yield of [(18)F]3 was 16.4 +/- 4.8% (n = 4

237 Radiolabeling of cm09 was achieved with a radiochemical yield of greater than 96% at a specific ac

238 (47)Sc-cm10 was prepared with a radiochemical yield of more than 96% at a specific activ

239 led at a specific activity of 40 MBq/nmol, a radiochemical yield of more than 98%, and a stability of

240 The radiochemical yield strongly depended on the iodonium co

241 uct in approximately 20%-40% decay-corrected radiochemical yield to provide (18)F-nifrolidine specifi

242 ion (t(1/2) = 109.7 min) in moderately high radiochemical yield to provide potential radioligands th

243 -MMR 3.49 sdAb was synthesized with a 5%-10% radiochemical yield using an automated and optimized pro

244 The decay-corrected radiochemical yield was 1.40% +/- 0.16% (n = 4), and the

245 The radiochemical yield was 13% +/- 3% (n = 7, decay-correct

246 The radiochemical yield was 20%-25%.

247 The radiochemical yield was 20%-30% decay corrected with an

248 sis time was 63 min, and the decay-corrected radiochemical yield was 36% +/- 3% (n = 8).

249 Radiochemical yield was 6%-35%, specific activity was 15

250 The typical decay-corrected radiochemical yield was about 30%-40% for both tracers,

251 [(76)Br]5 was prepared in a 51% +/- 19% radiochemical yield with high radiochemical purity (>/=9

252 ic activities as high as 2.3 mCi/nmol (97.5% radiochemical yield) is presented.

253 The peptide was efficiently labeled (91-98% radiochemical yield) with Tc-99m in the presence of tric

254 ere synthesized within approximately 70 min (radiochemical yield, 35%-45%; specific activity, 650-870

255 lly pure l-[5-(11)C]-glutamine was obtained (radiochemical yield, 5% at the end of synthesis; radioch

256 igands succeeded after optimization efforts (radiochemical yield, approximately 20%-30% at the end of

257 The radiochemical yield, calculated from initial cyclotron-p

258 d to synthesize the radiotracer with optimal radiochemical yield, purity, and immunoreactivity.

259 Radiolabeling was accomplished with high radiochemical yield, purity, and specific radioactivity.

260 t 79% +/- 13% (n = 6) and 94% +/- 6% (n = 6) radiochemical yield, respectively, with excellent radioc

261 i) of [(18)F]fluoride in 50 min (uncorrected radiochemical yield, specific activity of 815 +/- 185 GB

262 (18)F-SFB was produced with a 34%-38% radiochemical yield.

263 extremely small scale (20 nmol) with a high radiochemical yield.

264 %) radiochemical purity and greater than 80% radiochemical yield.

265 d electrophilic iododestannylation in 60-90% radiochemical yield.

266 ynthesis of tracers was accomplished in good radiochemical yields (15-39%), high specific activities

267 bioactive molecules and building blocks with radiochemical yields (RCY) ranging from 20% to 72% withi

268 r = Ph or 2-MeC(6)H(4), 85%) decay-corrected radiochemical yields (RCYs) of a single radioactive prod

269 of a variety of arenes and heteroarenes with radiochemical yields (RCYs, not decay-corrected) from 10

270 (18)F]5 was synthesized in reproducibly high radiochemical yields and purity (>98%) as well as high s

271 iolabeling with (89)Zr was performed in high radiochemical yields and purity (>99%), and binding affi

272 as efficient and gave radioligands with high radiochemical yields and purity.

273 A comparison of radiochemical yields and reaction times for a microfluid

274 d lorlatinib is routinely prepared with good radiochemical yields and shows reasonable tumour uptake

275 thesized in 140 min with 24% and 10% overall radiochemical yields and specific activities of 10-127 G

276 The non-decay-corrected radiochemical yields based on starting (18)F-fluoride us

277 ound 4-(11)C-MBZA was prepared in 46% +/- 7% radiochemical yields by reacting (11)C-methyltriflate wi

278 ound 4-(11)C-MBZA was prepared in 46% +/- 7% radiochemical yields by reacting (11)C-methyltriflate wi

279 precursor-based synthesis demonstrated high radiochemical yields in the large-scale production of ra

280 In the latter case, the radiochemical yields increased, and degradation of the 2

281 step procedure using a microwave system with radiochemical yields of 26.9 +/- 4.7%.

282 2 and 13, respectively, with decay-corrected radiochemical yields of 30% for [18F]16 and 20% for [18F

283 8F]SFB can be synthesized in decay-corrected radiochemical yields of 30%-35% and a specific radioacti

284 Fluorinated pH indicators were produced with radiochemical yields of 4%-11% at greater than 90% purit

285 taurine-conjugated bile acids proceeded with radiochemical yields of 61% (decay-corrected) or greater

286 7alpha-18F-FM-DHT and 7alpha-18F-FM-norT in radiochemical yields of about 30% and radiochemical puri

287 F]/F(-) and Kryptofix/K(2)CO(3) in DMSO with radiochemical yields of approximately 50-60% and specifi

288 t (67/68)Ga and (177)Lu labeling resulted in radiochemical yields of greater than 97% or greater than

289 ynthesized in 20% +/- 5% (n = 3) uncorrected radiochemical yields relative to (18)F-fluoride, with sp

290 The overall decay-corrected radiochemical yields were 26-51%.

291 Radiochemical yields were approximately 10-fold higher,

292 (89)Zr-ACKR3-mAb was produced in 80% +/- 5% radiochemical yields with greater than 98% radiochemical

293 obtained in greater than 50% decay-corrected radiochemical yields with more than 99% radiochemical pu

294 roblematic due to long synthesis times, poor radiochemical yields, and low specific activities.

295 , with [(11)C]iodomethane in 28, 11, and 14% radiochemical yields, respectively.

296 obtained in 16.3%-36.8% non-decay-corrected radiochemical yields, with 40-207 GBq/mumol specific act

297 corrected), and 59-75% (nondecay-corrected) radiochemical yields.

298 peroxide as the oxidant gives [*I]SIB in 80% radiochemical yields.

299 64 formed complexes with ligands 1-4 in high radiochemical yields.

300 nced Cu-mediated radiofluorination in 30-53% radiochemical yields.